Home/Filings/4/0001736297-25-000086
4//SEC Filing

Mohan Jitendra 4

Accession 0001736297-25-000086

CIK 0001736297other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 4:47 PM ET

Size

17.2 KB

Accession

0001736297-25-000086

Insider Transaction Report

Form 4
Period: 2025-07-21
Mohan Jitendra
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-07-21$112.72/sh12,710$1,432,716725,420 total(indirect: By Trust)
  • Sale

    Common Stock

    2025-07-21$112.72/sh12,710$1,432,716725,420 total(indirect: By Trust)
  • Sale

    Common Stock

    2025-07-21$112.72/sh12,710$1,432,716475,421 total(indirect: By Trust)
  • Sale

    Common Stock

    2025-07-21$112.72/sh12,710$1,432,716475,421 total(indirect: By Trust)
  • Sale

    Common Stock

    2025-07-21$112.72/sh12,708$1,432,4904,305,425 total(indirect: By Trust)
  • Sale

    Common Stock

    2025-07-21$112.72/sh12,710$1,432,716725,413 total(indirect: By Trust)
Holdings
  • Common Stock

    2,262,318
Footnotes (8)
  • [F1]The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024.
  • [F2]The price reported in Column 4 is a weighted average price of the aggregate number of shares sold. These shares were sold in multiple transactions in bulk with 16,071 shares sold at prices ranging from $110.7100 to $111.6550, 31,327 shares sold at prices ranging from $111.7800 to $112.7750, 9,561 shares sold at prices ranging from $112.7900 to $113.7500, 13,172 shares sold at prices ranging from $113.9100 to $114.7200, and 6,127 shares sold at prices ranging from $114.9100 to $115.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F4]These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F5]These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F6]These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F7]These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F8]These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Issuer

Astera Labs, Inc.

CIK 0001736297

Entity typeother

Related Parties

1
  • filerCIK 0001998053

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:47 PM ET
Size
17.2 KB